Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,059 | 5,767 | 2,697 | 4,682 | 8,202 |
| Marketable Securities | 78 | 46 | 64 | 111 | 178 |
| Receivables | 3,567 | 2,730 | 4,383 | 5,160 | 5,239 |
| TOTAL | $12,704 | $8,543 | $7,144 | $9,953 | $13,619 |
| Non-Current Assets | |||||
| PPE Net | 30 | 33 | 36 | 37 | 40 |
| Other Non-Current Assets | 66 | 1,272 | 994 | 1,761 | 8 |
| TOTAL | $96 | $1,305 | $1,030 | $1,798 | $48 |
| Total Assets | $12,800 | $9,848 | $8,174 | $11,751 | $13,667 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 909 | 1,926 | 2,766 | 1,715 | 1,955 |
| TOTAL | $1,501 | $2,473 | $3,271 | $3,125 | $3,918 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 556 | 511 | 469 | 1,410 | 1,963 |
| Other Non-Current Liabilities | 22 | 29 | 39 | 0 | 0 |
| TOTAL | $2,143 | $2,306 | $2,461 | $1,570 | $1,308 |
| Total Liabilities | $3,644 | $4,779 | $5,732 | $4,695 | $5,226 |
| Shareholders' Equity | |||||
| Common Shares | 29,234 | 18,560 | 8,225 | 8,153 | 6,747 |
| Retained earnings | -119,261 | -115,368 | -110,311 | -108,464 | -105,516 |
| Other shareholders' equity | 1,127 | 1,127 | 1,127 | 7,142 | 7,078 |
| TOTAL | $9,156 | $5,069 | $2,442 | $7,056 | $8,441 |
| Total Liabilities And Equity | $12,800 | $9,848 | $8,174 | $11,751 | $13,667 |